BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM • FR0013280286

95.25 EUR
+0.95 (+1.01%)
Last: Feb 20, 2026, 05:35 PM
Fundamental Rating

6

BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BIM had positive earnings in the past year.
  • In the past year BIM had a positive cash flow from operations.
  • In the past 5 years BIM has always been profitable.
  • In the past 5 years BIM always reported a positive cash flow from operatings.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • BIM has a better Return On Assets (7.04%) than 82.09% of its industry peers.
  • BIM's Return On Equity of 9.61% is fine compared to the rest of the industry. BIM outperforms 64.18% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.56%, BIM is in the better half of the industry, outperforming 70.15% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 9.66%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.56%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of BIM (9.17%) is better than 67.16% of its industry peers.
  • In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
  • The Operating Margin of BIM (12.38%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BIM has grown nicely.
  • BIM has a Gross Margin (56.27%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
  • The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BIM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BIM has an improved debt to assets ratio.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 6.07 indicates that BIM is not in any danger for bankruptcy at the moment.
  • BIM has a Altman-Z score of 6.07. This is amongst the best in the industry. BIM outperforms 89.55% of its industry peers.
  • The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BIM (1.15) is better than 83.58% of its industry peers.
  • BIM has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.09, BIM is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6.07
ROIC/WACC1.07
WACC8.01%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.27, BIM is doing good in the industry, outperforming 64.18% of the companies in the same industry.
  • BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.30, BIM is doing good in the industry, outperforming 61.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

  • The earnings per share for BIM have decreased by -8.45% in the last year.
  • Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
  • BIM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.28%.
  • Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.63% on average over the next years. This is quite good.
  • Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 5.84% on average per year.
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.63%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.84%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2032 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • BIM is valuated rather expensively with a Price/Earnings ratio of 24.68.
  • Compared to the rest of the industry, the Price/Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 61.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.09, BIM is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 19.03, the valuation of BIM can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BIM.
  • The average S&P500 Price/Forward Earnings ratio is at 27.98. BIM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.68
Fwd PE 19.03
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than 76.12% of the companies in the same industry.
  • 67.16% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.69
EV/EBITDA 11.43
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of BIM may justify a higher PE ratio.
  • A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)1.55
PEG (5Y)2.26
EPS Next 2Y13.86%
EPS Next 3Y13.5%

3

5. Dividend

5.1 Amount

  • BIM has a yearly dividend return of 0.97%, which is pretty low.
  • BIM's Dividend Yield is comparable with the industry average which is at 1.14.
  • Compared to an average S&P500 Dividend Yield of 1.85, BIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

  • On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BIM pays out 28.07% of its income as dividend. This is a sustainable payout ratio.
  • BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (2/20/2026, 5:35:15 PM)

95.25

+0.95 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)03-04
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap11.27B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target122.03 (28.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.92%
PT rev (3m)-4.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 24.68
Fwd PE 19.03
P/S 2.74
P/FCF 25.69
P/OCF 14.32
P/B 2.87
P/tB 4.03
EV/EBITDA 11.43
EPS(TTM)3.86
EY4.05%
EPS(NY)5
Fwd EY5.25%
FCF(TTM)3.71
FCFY3.89%
OCF(TTM)6.65
OCFY6.99%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.55
PEG (5Y)2.26
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.7%
ROIC 8.56%
ROICexc 9.38%
ROICexgc 13.1%
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.43%
Cap/Sales 8.46%
Interest Coverage 250
Cash Conversion 79.94%
Profit Quality 116.09%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6.07
F-Score8
WACC8.01%
ROIC/WACC1.07
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.63%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.84%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.85%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.